Antioxidant drug therapy as a neuroprotective countermeasure of nerve agent toxicity.


Journal

Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169

Informations de publication

Date de publication:
01 2020
Historique:
received: 07 01 2019
revised: 18 04 2019
accepted: 23 04 2019
pubmed: 28 4 2019
medline: 15 12 2020
entrez: 28 4 2019
Statut: ppublish

Résumé

The use of chemical warfare agents is an ongoing, significant threat to both civilians and military personnel worldwide. Nerve agents are by far the most formidable toxicants in terms of their lethality and toxicity. Nerve agents initiate neurotoxicity by the irreversible inhibition of acetylcholinesterase and resultant accumulation of acetylcholine in excitable tissues. The cholinergic toxidrome presents as miosis, lacrimation, diarrhea, fasciculations, seizures, respiratory arrest and coma. Current medical countermeasures can attenuate acute mortality and confer limited protection against secondary neuronal injury when given rapidly after exposure. However, there is an urgent need for the development of novel, add-on neuroprotective therapies to prevent mortality and long-term toxicity of nerve agents. Increasing evidence suggests that pathways other than direct acetylcholinesterase inhibition contribute to neurotoxicity and secondary neuronal injury. Among these, oxidative stress is emerging as a key therapeutic target for nerve agent toxicity. In this review, we discuss the rationale for targeting oxidative stress in nerve agent toxicity and highlight research investigating antioxidant therapy as a neuroprotective medical countermeasure to attenuate oxidative stress, neuroinflammation and neurodegeneration.

Identifiants

pubmed: 31028872
pii: S0969-9961(19)30102-0
doi: 10.1016/j.nbd.2019.04.013
pmc: PMC7721294
mid: NIHMS1650456
pii:
doi:

Substances chimiques

Antioxidants 0
Nerve Agents 0
Neuroprotective Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104457

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS039587
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS072099
Pays : United States
Organisme : NINDS NIH HHS
ID : R37 NS039587
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS083422
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Références

Toxicol Sci. 2018 Apr 1;162(2):611-621
pubmed: 29272548
Neurosci Biobehav Rev. 1993 Summer;17(2):203-15
pubmed: 8515903
Biophys J. 2007 Dec 15;93(12):4225-36
pubmed: 17766354
Ann Neurol. 1982 Dec;12(6):518-28
pubmed: 6984318
Neurobiol Dis. 2015 Oct;82:289-297
pubmed: 26184893
Neurotoxicology. 2001 Apr;22(2):271-82
pubmed: 11405258
J Biochem Mol Toxicol. 2014 Jul;28(7):320-7
pubmed: 24865641
Microbes Infect. 2009 Nov;11(13):1050-62
pubmed: 19733681
Neurotoxicol Teratol. 2016 Jul-Aug;56:81-86
pubmed: 27224207
FEBS Lett. 1978 Feb 1;86(1):139-42
pubmed: 202505
Ann N Y Acad Sci. 2000;899:191-208
pubmed: 10863540
Drug Discov Today. 2004 Jul 1;9(13):557-66
pubmed: 15203091
Apoptosis. 2007 May;12(5):913-22
pubmed: 17453160
Free Radic Biol Med. 2010 May 1;48(9):1188-96
pubmed: 20138141
Proc Am Thorac Soc. 2010 Jul;7(4):254-6
pubmed: 20601628
Hum Exp Toxicol. 2003 Apr;22(4):205-11
pubmed: 12755471
Arch Toxicol. 2001 Aug;75(6):346-56
pubmed: 11570692
Free Radic Biol Med. 2014 Jul;72:285-95
pubmed: 24815113
Neurotoxicology. 2014 Sep;44:17-26
pubmed: 24785379
Neurosci Lett. 2010 Nov 5;484(3):187-91
pubmed: 20732386
Am J Physiol. 1996 Nov;271(5 Pt 1):C1424-37
pubmed: 8944624
Am J Respir Cell Mol Biol. 2011 Aug;45(2):323-31
pubmed: 21642592
Redox Biol. 2019 Jan;20:275-284
pubmed: 30384261
BMJ. 2017 Apr 12;357:j1807
pubmed: 28404565
Biochim Biophys Acta. 2015 Mar;1852(3):507-19
pubmed: 25460197
Acta Pharmacol Toxicol (Copenh). 1985 Sep;57(3):190-6
pubmed: 4061100
Hum Exp Toxicol. 1992 Nov;11(6):517-23
pubmed: 1361142
Food Chem Toxicol. 2008 Jan;46(1):82-6
pubmed: 17706853
Exp Neurol. 2017 Dec;298(Pt A):13-22
pubmed: 28822838
Basic Clin Pharmacol Toxicol. 2008 Apr;102(4):365-9
pubmed: 18341513
Free Radic Biol Med. 2008 Mar 15;44(6):921-37
pubmed: 18155672
J Neurosci. 2009 Feb 25;29(8):2545-52
pubmed: 19244529
Environ Toxicol Pharmacol. 1999 Apr;7(2):147-52
pubmed: 21781920
N Engl J Med. 1985 Jan 17;312(3):159-63
pubmed: 2981404
Toxicol Appl Pharmacol. 2009 Oct 15;240(2):124-31
pubmed: 19615394
Nat Med. 2013 Oct;19(10):1194-5
pubmed: 24100968
Free Radic Res. 1999 Dec;31(6):577-96
pubmed: 10630682
Neurotoxicology. 2007 Nov;28(6):1208-19
pubmed: 17850875
Arch Biochem Biophys. 1997 Nov 15;347(2):256-62
pubmed: 9367533
AAPS J. 2017 Jul;19(4):973-988
pubmed: 28550637
Toxicol Mech Methods. 2007;17(9):535-40
pubmed: 20020880
Brain Res. 2013 Mar 7;1499:163-72
pubmed: 23313582
J Toxicol Environ Health A. 2017;80(19-21):1106-1115
pubmed: 28849997
Ann N Y Acad Sci. 2016 Jun;1374(1):176-83
pubmed: 27327161
Free Radic Biol Med. 2011 Mar 1;50(5):602-8
pubmed: 21156205
Indian J Exp Biol. 1992 Apr;30(4):352-4
pubmed: 1459609
Neuroscience. 2000;101(3):563-70
pubmed: 11113305
Toxicol Appl Pharmacol. 2011 Jun 15;253(3):261-9
pubmed: 21513723
Hum Exp Toxicol. 1999 Mar;18(3):174-9
pubmed: 10215108
Trends Pharmacol Sci. 2016 Sep;37(9):768-778
pubmed: 27491897
Radiat Res. 2017 Mar;187(3):298-318
pubmed: 28208025
Environ Toxicol Pharmacol. 2005 Jul;20(1):88-91
pubmed: 21783573
J Neuroinflammation. 2016 Oct 12;13(1):267
pubmed: 27733171
Science. 1982 Oct 1;218(4567):64-6
pubmed: 6981843
J Neurochem. 1995 Nov;65(5):2016-21
pubmed: 7595485
Epilepsia. 1994 Jul-Aug;35(4):813-22
pubmed: 8082628
Neurochem Res. 2017 Jul;42(7):2024-2032
pubmed: 28462450
Epilepsy Res. 1995 Jan;20(1):77-84
pubmed: 7713062
Environ Toxicol. 2017 Jun;32(6):1754-1764
pubmed: 28233943
Toxicol Sci. 2016 Dec;154(2):341-353
pubmed: 27605419
J Neurosci. 2012 Aug 15;32(33):11250-8
pubmed: 22895709
Neurotox Res. 2003;5(3):177-82
pubmed: 12835122
Toxicol Sci. 2004 Apr;78(2):241-7
pubmed: 14976354
Biochem Pharmacol. 2004 Jan 1;67(1):77-85
pubmed: 14667930
Environ Health Perspect. 2007 Jan;115(1):93-101
pubmed: 17366826
Neurotoxicology. 2006 Dec;27(6):931-9
pubmed: 16982099
J Appl Toxicol. 2001 Dec;21 Suppl 1:S87-94
pubmed: 11920927
Toxicol Sci. 2010 Aug;116(2):623-31
pubmed: 20498005
Environ Toxicol Pharmacol. 1997 Feb 15;3(1):53-6
pubmed: 21781758
J Neurochem. 2005 Jan;92(1):123-31
pubmed: 15606902
Toxicology. 2005 Feb 14;207(2):283-91
pubmed: 15596258
Health Phys. 2014 Jan;106(1):73-83
pubmed: 24276551
Toxicol Sci. 2007 May;97(1):140-8
pubmed: 17327255
Neurotoxicology. 2012 Mar;33(2):156-61
pubmed: 22285544
J Appl Toxicol. 1997 Jul-Aug;17(4):255-64
pubmed: 9285539
J Physiol. 2003 Oct 15;552(Pt 2):335-44
pubmed: 14561818
Eur J Pharmacol. 1989 Oct 17;172(4-5):413-6
pubmed: 2555211
J Occup Health. 2005 Jul;47(4):299-304
pubmed: 16096354
Neurosci Biobehav Rev. 1991 Fall;15(3):349-62
pubmed: 1683477
Neurobiol Dis. 2011 Jun;42(3):482-95
pubmed: 21397025
Arch Toxicol. 1999 Jun-Jul;73(4-5):269-73
pubmed: 10463393
Free Radic Biol Med. 1999 Mar;26(5-6):730-6
pubmed: 10218663
Epilepsia. 2010 Aug;51(8):1503-10
pubmed: 20067510
Mil Med Res. 2018 Sep 6;5(1):30
pubmed: 30185231
J Biol Chem. 2001 Feb 16;276(7):4588-96
pubmed: 11092892
Toxicol Appl Pharmacol. 2007 Mar;219(2-3):181-9
pubmed: 17084875
Hum Exp Toxicol. 2002 Apr;21(4):179-82
pubmed: 12099619
Mol Cells. 2011 Dec;32(6):491-509
pubmed: 22207195
J Neuroinflammation. 2015 Apr 02;12:64
pubmed: 25880399

Auteurs

Jennifer N Pearson-Smith (JN)

Department of Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, 80045, United States of America.

Manisha Patel (M)

Department of Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, 80045, United States of America. Electronic address: Manisha.Patel@ucdenver.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH